J.M. Harris et al. / Carbohydrate Research 328 (2000) 17–36
27
separated and the aq layer was extracted with
(5×20 mL) of Et2O. The organic fractions
were combined, dried (MgSO4), concentrated,
and purified by silica gel chromatography
eluting with 1:3 Et2O–hexanes to yield 29 mg
(0.092 mmol, 92%) of alcohol 9d: Rf 0.25 (1:3
Et2O–hexanes); [h]2D1 36.1° (c 2.80, CHCl3); IR
(thin film, cm−1) 3156, 2976, 2874, 1728,
Hz, 1 H), 4.54 (dd, J 12.5, 5.0 Hz, 1 H), 4.28
(dd, J 12.0, 2.0 Hz, 1 H), 4.09 (ddd, J 9.0, 6.0,
2.0 Hz, 1 H), 3.95 (dddd, J 9.5, 4.5, 2.0 Hz, 1
13
H), 2.90 (d, J 6.0 Hz, 1 H), 1.16 (s, 9 H); C
NMR (125 MHz, CDCl3) l 179.7, 165.4,
134.6, 133.3, 129.8, 129.7, 128.4, 124.5, 88.9,
72.8, 63.3, 63.2, 38.9, 27.1; CIHRMS Calcd
for [C18H22O6+NH4]+: 352.1760. Found:
352.1739.
1
1480, 1462, 1283; H NMR (500 MHz, C6D6)
(2S,5S,6R)-6-(tert-Butyldimethylsilanyloxy-
methyl)-5-hydroxy-5,6-dihydro-2H-pyran-2-yl
pi6alate (9c).—Compound 8c (85 mg, 0.25
mmol) was dissolved in 1.5 mL of CH2Cl2 and
cooled to −78 °C with a dry ice–acetone
bath. To the solution, 2 mL of a 0.4 M
solution of CeCl3 in MeOH was added, fol-
lowed by NaBH4 (12 mg, 0.30 mmol), and the
solution was stirred for 1.5 h. The reaction
was warmed to 0 °C, and 20 mL of Et2O and
20 mL of H2O were added to the solution.
The phases were separated and the aq layer
was extracted with (5×20 mL) of Et2O. The
organic fractions were combined, dried
(MgSO4), concentrated, and purified by silica
gel chromatography eluting with 1:9 EtOAc–
hexanes to yield 82 mg (0.24 mmol, 95%) of
alcohol 9c: Rf 0.40 (1:4 EtOAc–hexanes); [h]D21
l 6.36 (d, J 2.7 Hz, 1 H), 5.76 (dt, J 10.2, 1.2
Hz, 1 H), 5.34 (ddd, J 10.0, 2.7, 1.8 Hz, 1 H),
4.38 (dd, J 12.3, 5.4 Hz, 1 H), 4.18 (dd, J 12.3,
2.1 Hz, 1 H), 3.87 (ddd, J 9.3, 5.3, 2.1 Hz, 1
H), 3.79 (d, J 9.9 Hz, 1 H), 2.39 (bs, 1 H), 1.11
(s, 9 H), 1.08 (s, 9 H); 13C NMR (125 MHz,
CDCl3) l 179.8, 177.4, 134.2, 124.7, 110.4,
88.2, 72.6, 66.5, 63.3, 39.0, 27.2; FABHRMS
Calcd for [C16H26O6+Na]+: 337.1627.
Found: 337.1634.
(2S,5S,6R)-6-(tert-Butyldimethylsilanyloxy-
methyl)-5-ethoxycarbonyloxy-5,6-dihydro-2H-
pyran-2-yl benzoate (9e).—Compound 9a
(190 mg, 0.521 mmol) was dissolved in 5 mL
of CH2Cl2 and cooled to −78 °C. Pyridine
(85 mL, 1.0 mmol) and DMAP (7 mg, 0.05
mmol) were added to the solution, followed
by ethyl chloroformate (75 mL, 0.78 mmol),
and the solution was stirred for 3 h. The
reaction was warmed to 0 °C, and 30 mL of
Et2O and 30 mL of satd aq NaHCO3 were
added to the solution. The phases were sepa-
rated, and the aq layer was extracted (3×20
mL) with Et2O. The organic fractions were
combined, dried (MgSO4), concentrated, and
purified by silica gel chromatography eluting
with 1:4 Et2O–hexanes to yield 185 mg (0.424
mmol, 81%) of carbonate 9e: Rf 0.3 (1:4
Et2O–hexanes); [h]2D1 −20.3° (c 2.00, CH2Cl2);
IR (thin film, cm−1) 2925, 2841, 1725, 1256;
1H NMR (500 MHz, CDCl3) l 8.05 (dd, J 8.5,
1.0 Hz, 2 H), 7.58 (tt, J 8.5, 7.5, 1.5 Hz, 1 H),
7.44 (tt, J 7.5, 1.5 Hz, 2 H), 6.57 (d, J 3.0 Hz,
1 H), 6.17 (d, J 10.0 Hz, 1 H), 5.98 (ddd, J
10.0, 3.0, 2.0 Hz, 1 H), 5.33 (ddd, J 9.5, 3.5,
2.0 Hz, 1 H), 4.24 (q, J 14.5, 7.0 Hz, 2 H),
4.07 (ddd, J 9.0, 3.5, 3.5 Hz, 1 H), 3.83 (m, 2
H), 1.33 (t, J 7.5 Hz, 3 H), 0.84 (s, 9 H), 0.04
(s, 3 H), 0.03 (s, 3 H); 13C NMR (125 MHz,
CDCl3) l 165.2, 154.3, 133.3, 130.6, 129.8,
128.4, 126.2, 88.7, 71.6, 68.1, 64.4, 62.2, 25.8,
18.3, 14.2, −5.4, −5.5; FABHRMS Calcd
−17.7° (c 1.42, CH2Cl2); IR (thin film, cm−1
)
3496, 2957, 2929, 2857, 1742, 1472, 1463,
1
1280, 1255; H NMR (500 MHz, CDCl3) l
6.22 (dd, J 3.0, 1.5 Hz, 1 H), 6.06 (dd, J 10.0,
1.5 Hz, 1 H), 5.74 (ddd, J 10.0, 3.0, 3.0 Hz, 1
H), 4.26 (dd, J 6.5, 2.0 Hz, 1 H), 3.94 (dd, J
8.0, 3.0 Hz, 1 H), 3.92 (dd, J 8.0, 3.0 Hz, 1 H),
3.74 (m, 2 H), 3.20 (d, J 2.5 Hz, 2 H), 1.22 (s,
9 H), 0.91 (s, 9 H), 0.11 (s, 3 H), 0.10 (s, 3 H);
13C NMR (125 MHz, CDCl3) l 177.5, 134.8,
124.0, 87.7, 71.5, 67.1, 65.7, 38.0, 25.8, 18.2,
−5.5, −5.6; CIHRMS Calcd for [C17H32-
O5Si−C5H9O2]+: 243.1416. Found: 243.1416.
(2S,5S,6R) - 6 - (Pi6aloyloxymethyl) - 5-
hydroxy-5,6-dihydro-2H-pyran-2-yl pi6alate
(9d).—Compound 8d (31 mg, 0.10 mmol) was
dissolved in 0.5 mL of CH2Cl2 and cooled to
−78 °C with a dry ice–acetone bath. To the
solution 1 mL of a 0.4 M solution of CeCl3 in
MeOH was added, followed by NaBH4 (3.8
mg, 0.10 mmol), and the solution was stirred
for 0.5 h. The reaction was warmed to 0 °C,
and 20 mL of Et2O and 20 mL of NaHCO3
were added to the solution. The phases were